| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Medical Officer
1 company
Shames Richard S. is a Chief Medical Officer at Protagonist Therapeutics, Inc. Recent SEC Form 4 filings include 0 buys and 7 sells.
Estimated insider holdings value: $3.7M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Mar 1, 2019 | PTGX Protagonist Therapeutics, Inc | Chief Medical Officer | Sell | 657 | $8.03 | $5,275.71 | -2.0% | |
| Feb 6, 2019 | PTGX Protagonist Therapeutics, Inc | Chief Medical Officer | Sell | 2,778 | $7.74 | $21,505.50 | -5.2% | |
| Dec 22, 2017 | PTGX Protagonist Therapeutics, Inc | Chief Medical Officer | Sale+OE | 3,529 | $20.50 | $72,344.50 | -100% | |
| Oct 5, 2017 | PTGX Protagonist Therapeutics, Inc | Chief Medical Officer | Sale+OE | 2,017 | $19.00 | $38,323.00 | -100% | |
| Sep 12, 2017 | PTGX Protagonist Therapeutics, Inc | Chief Medical Officer | Sell | 3,687 | $14.31 | $52,752.86 | -100% | |
| Aug 29, 2017 | PTGX Protagonist Therapeutics, Inc | Chief Medical Officer | Sale+OE | 1,512 | $17.00 | $25,704.00 | -44.8% |